⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2809033 | 0.67 | — | — | |
| SCHEMBL1278079 | 0.61 | — | — | |
| SCHEMBL18479747 | 0.61 | — | — | |
| SCHEMBL6051861 | 0.61 | — | — | |
| SCHEMBL18843427 | 0.61 | KDM4E (0.31) | — | |
| SCHEMBL14331814 | 0.61 | — | — | |
| SCHEMBL420124 | 0.61 | — | — | |
| SCHEMBL1457573 | 0.61 | — | — | |
| SCHEMBL145953 | 0.61 | — | — | |
| SCHEMBL14914148 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7119103-B2 | β3-Adrenoreceptor agonists, agonist compositions and methods of using | MOLECULAR DESIGN INTERNATIONAL, INC. (US) | 2006-10-10 | — | — | US | disclosed |
| US-20050096347-A1 | Beta3-Adrenoreceptor agonists, agonist compositions and methods of using | MOLECULAR DESIGN INTERNATIONAL, INC. | 2005-05-05 | — | — | US | disclosed |
| US-6825213-B2 | NITROGEN COMPOUNDS SUCH AS 1-(4-AMINO-3,5-DIIODOBENZYL)-6,7-DIMETHOXY-1,2,3,4-TETRAHYDROISOQUINOLINE, USED AS ADRENERGIC STIMULANTS FOR PROPHYLAXIS OF METABOLIC DISORDERS; OBESITY | MOLECULAR DESIGN INTERNATIONAL, INC. | 2004-11-30 | — | — | US | disclosed |
| US-20040019079-A1 | Beta3-Adrenoreceptor agonists, agonist compositions and methods of using | FELLER DENNIS R (US) | 2004-01-29 | — | — | US | disclosed |
| EP-1023269-A4 | BETA3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF USING | MOLECULAR DESIGN INT (US) | 2001-06-27 | — | — | EP | disclosed |
| EP-1023269-A1 | BETA3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF USING | MOLECULAR DESIGN INTERNATIONAL, INC. (US) | 2000-08-02 | — | — | EP | disclosed |
| WO-1999016752-A1 | β3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF USING | MOLECULAR DESIGNS INTERNATIONAL, INC. (US) | 1999-04-08 | — | — | WO | disclosed |